CD8A and breast angiosarcoma: In most of BA patients, this microenvironment is pro-inflammatory (Th1), characterized by IFN-γ production and the activation of effector cells (macrophages, CD8+ T cells and B cells) to perpetuate the tissue damage (Figure 3D) (11, 16).